XML 45 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Agreements with Endospan (Details)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended
Jul. 01, 2024
USD ($)
tranche
Jun. 30, 2024
USD ($)
Sep. 11, 2019
USD ($)
tranche
May 31, 2023
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Variable Interest Entity [Line Items]                        
Number of tranches | tranche     3                  
Expense             $ (2,386,000) $ 1,911,000     $ 6,000 $ 5,189,000
Variable Interest Entity, Primary Beneficiary                        
Variable Interest Entity [Line Items]                        
Securities purchase option agreement           $ 1,000,000            
Option to purchase outstanding securities $ 175,000,000 $ 250,000,000                    
Securities purchase option agreement, expiration period           90 days            
Minimum amount of future consideration payment 0                      
Securities purchase option agreement, payment 100,000,000                      
Maximum amount of future consideration payment 200,000,000                      
Securities purchase option agreement, fair value             3,100,000          
Loan provided $ 25,000,000   $ 15,000,000                  
Number of tranches | tranche 3                      
Funding of loan agreement per tranche     5,000,000                  
Funded second tranche payment       $ 5,000,000 $ 5,000,000              
Required percentage of number of patients before tranche of loan funding can be acquired       50.00%                
Loans at fair value                 $ 0 $ 0    
Expense                 $ 5,000,000 $ 5,000,000    
Variable Interest Entity, Primary Beneficiary | Upfront Acquisition Purchase Price                        
Variable Interest Entity [Line Items]                        
Option to purchase outstanding securities $ 135,000,000                      
Variable Interest Entity, Primary Beneficiary | Tranche One                        
Variable Interest Entity [Line Items]                        
Funding of loan agreement per tranche 7,000,000           7,000,000          
Variable Interest Entity, Primary Beneficiary | Tranche Two                        
Variable Interest Entity [Line Items]                        
Funding of loan agreement per tranche 10,000,000                      
Variable Interest Entity, Primary Beneficiary | Tranche Three                        
Variable Interest Entity [Line Items]                        
Funding of loan agreement per tranche $ 8,000,000                      
Variable Interest Entity, Primary Beneficiary | Endospan Loan | After Funding of First Tranche Payment                        
Variable Interest Entity [Line Items]                        
Loans at fair value             298,000       298,000  
Variable Interest Entity, Primary Beneficiary | Endospan Loans | Tranche One                        
Variable Interest Entity [Line Items]                        
Loans at fair value             $ 3,800,000       $ 3,800,000  
Variable Interest Entity, Primary Beneficiary | Minimum                        
Variable Interest Entity [Line Items]                        
Option to purchase outstanding securities           $ 350,000,000.0            
Variable Interest Entity, Primary Beneficiary | Maximum                        
Variable Interest Entity [Line Items]                        
Option to purchase outstanding securities           $ 450,000,000            
Variable Interest Entity, Primary Beneficiary | JOTEC GmbH                        
Variable Interest Entity [Line Items]                        
Distribution fee     $ 9,000,000